fig2

From: Immune checkpoint inhibitors in hepatocellular carcinoma therapy: resistance mechanisms, liver transplantation challenges and management strategies

Immune checkpoint inhibitors in hepatocellular carcinoma therapy: resistance mechanisms, liver transplantation challenges and management strategies

Figure 2. A clinical management flowchart for ICI use in LT candidates (created with BioGDP.com). ICI: Immune checkpoint inhibitor; LT: liver transplantation.

Cancer Drug Resistance

ISSN 2578-532X (Online)

[email protected]

Navigation

Sitemap

Navigation

Sitemap

Committee on Publication Ethics

https://members.publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Discover Content

Strategic Collaborators

Follow OAE

Privacy Cookies Terms of Service